Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Micron Technology, Inc. (MU) Stock Will Gain 21%

By Chris Lau, InvestorPlace Contributor

Micron's (MU) growth and earnings potential is overlooked by analysts, but MU stock holders will win when 3D XPoint rolls out.

3 Under-the-Radar Tech Stocks to Buy Before Investors Wisen Up

By Chris Lau, InvestorPlace Contributor

Undiscovered tech stocks are hard to find, but these three stocks are rather unnoticed and have tons of potential in the bigger picture.

Turnaround in Fitbit Inc (FIT) Stock Is Anything but Certain

By Chris Lau, InvestorPlace Contributor

Fitbit reported a better than expected quarter but it has plenty of work ahead. International growth and new products will help FIT stock.

Nvidia Corporation (NVDA) Stock Has Plenty of Growth Ahead

By Chris Lau, InvestorPlace Contributor

Nvidia is not just a graphics card supplier. NVDA stock is growing in markets outside of the PC space, including AI and autonomous driving.

Apple Inc.’s (AAPL) iPhone Potentially Under Threat From Samsung Galaxy 8

By Chris Lau, InvestorPlace Contributor

Apple should not take the threat of Samsung's S8 and S8+ release lightly. AAPL stock could see it cut into iPhone sales going forward.

Load More